Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599, USA.
Cell Rep. 2018 Sep 4;24(10):2669-2681.e5. doi: 10.1016/j.celrep.2018.08.011.
C. elegans vulval precursor cell (VPC) fates are patterned by an epidermal growth factor (EGF) gradient. High-dose EGF induces 1° VPC fate, and lower dose EGF contributes to 2° fate in support of LIN-12/Notch. We previously showed that the EGF 2°-promoting signal is mediated by LET-60/Ras switching effectors, from the canonical Raf-MEK-ERK mitogen-activated protein (MAP) kinase cascade that promotes 1° fate to the non-canonical RalGEF-Ral that promotes 2° fate. Of oncogenic Ras effectors, RalGEF-Ral is by far the least well understood. We use genetic analysis to identify an effector cascade downstream of C. elegans RAL-1/Ral, starting with an established Ral binding partner, Exo84 of the exocyst complex. Additionally, RAL-1 signals through GCK-2, a citron-N-terminal-homology-domain-containing MAP4 kinase, and PMK-1/p38 MAP kinase cascade to promote 2° fate. Our study delineates a Ral-dependent developmental signaling cascade in vivo, thus providing the mechanism by which lower EGF dose is transduced.
秀丽隐杆线虫的表皮生长因子 (EGF) 梯度决定了其生殖前体细胞 (VPC) 的命运。高剂量的 EGF 诱导 1° VPC 命运,而较低剂量的 EGF 则有助于支持 LIN-12/Notch 的 2°命运。我们之前曾表明,EGF 促进 2°命运的信号是由 LET-60/Ras 开关效应物介导的,从促进 1°命运的经典 Raf-MEK-ERK 丝裂原激活蛋白 (MAP) 激酶级联反应到促进 2°命运的非经典 RalGEF-Ral。在致癌性 Ras 效应物中,RalGEF-Ral 是迄今为止了解最少的。我们使用遗传分析来鉴定秀丽隐杆线虫 RAL-1/Ral 下游的效应物级联反应,从外泌体复合物的已建立的 Ral 结合伴侣 Exo84 开始。此外,RAL-1 通过 GCK-2(一种含有 citron-N 端同源结构域的 MAP4 激酶)和 PMK-1/p38 MAP 激酶级联反应传递信号,以促进 2°命运。我们的研究描绘了一个 Ral 依赖性的体内发育信号级联反应,从而提供了低剂量 EGF 转导的机制。